Company intelligence / Profile preview

NextSense

Mountain View, California, United Statesnextsense.com ↗

Ownership: Private
Development stage: Commercial

Overview

NextSense has developed a wearable in-ear EEG system that enables real-world, longitudinal brain data collection. The company is running clinical trials in epilepsy and sleep disorders and has received FDA Breakthrough Device designation for its approach to major depressive disorder with peripartum onset. Early results show promise for seizure prediction and improved management of neurological conditions through continuous monitoring outside the clinic.

Therapeutic areas: PsychiatryNeurology
Modalities: DeviceNon-pharmacological therapy (wearable neuro-sensing technology)
Industry: Physiological Monitoring

Partnerships

UCB PharmaHeraeusUC San DiegoEmory University

Beyond the preview

Go deeper on NextSense.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NextSense.

Explore the full profile